Production (Stage)
NurExone Biologic Inc.
NRXBF
$0.5318
$0.01011.94%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 588.00K | 700.00K | 2.52M | 2.39M | 3.26M |
| Total Receivables | 135.00K | 127.00K | 259.00K | 358.00K | 390.00K |
| Inventory | 600.00K | 600.00K | -- | -- | -- |
| Prepaid Expenses | -- | 166.00K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 41.00K | 41.00K | 41.00K | 41.00K | 32.00K |
| Total Current Assets | 1.36M | 1.63M | 2.82M | 2.78M | 3.68M |
|
|
|||||
| Total Current Assets | 1.36M | 1.63M | 2.82M | 2.78M | 3.68M |
| Net Property, Plant & Equipment | 776.00K | 807.00K | 791.00K | 508.00K | 465.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.14M | 2.44M | 3.61M | 3.29M | 4.14M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 187.00K | 339.00K | 172.00K | 173.00K | 231.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 2.00K | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 366.00K | 57.00K | 263.00K | 373.00K | 131.00K |
| Total Other Current Liabilities | 366.00K | 57.00K | 263.00K | 373.00K | 131.00K |
| Total Current Liabilities | 553.00K | 398.00K | 435.00K | 546.00K | 362.00K |
|
|
|||||
| Total Current Liabilities | 553.00K | 398.00K | 435.00K | 546.00K | 362.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 31.00K | 31.00K | 31.00K | 25.00K | 24.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 240.00K | 251.00K | 220.00K | 146.00K | 125.00K |
| Total Liabilities | 824.00K | 680.00K | 686.00K | 717.00K | 511.00K |
|
|
|||||
| Common Stock & APIC | 20.41M | 17.62M | 17.78M | 16.83M | 16.50M |
| Retained Earnings | -20.78M | -19.10M | -17.55M | -16.30M | -14.98M |
| Treasury Stock & Other | 1.68M | 3.24M | 2.70M | 2.05M | 2.11M |
| Total Common Equity | 1.32M | 1.76M | 2.93M | 2.58M | 3.63M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.32M | 1.76M | 2.93M | 2.58M | 3.63M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.32M | 1.76M | 2.93M | 2.58M | 3.63M |
|
|
|||||